ClinicalTrials.Veeva

Menu

Arch-Clamping Technique Under Mild Hypothermia in Treating With Acute Type A Aortic Dissection (AHEAD)

Capital Medical University logo

Capital Medical University

Status

Enrolling

Conditions

Acute Type A Aortic Dissection
Total Aortic Arch Replacement
Frozen Elephant Trunk
Hypothermia
Bilateral Antegrade Cerebral Perfusion

Treatments

Procedure: Total Arch Replacement combined Frozen Elephant Trunk Implantation using Bilateral Antegrade Cerebral Perfusion under Moderate Hypothermic Circulatory Arrest
Procedure: Arch-Clamping Technique under Moderate Hypothermia
Procedure: Arch-Clamping Technique under Mild Hypothermia

Study type

Interventional

Funder types

Other

Identifiers

NCT07150559
2023ZD0504402

Details and patient eligibility

About

The study is a multicenter, three-arm, open-label, randomized, parallel-controlled trial, which plans to enroll 306 participants diagnosed with acute type A aortic dissection (ATAAD) from 7 hospitals in China. All patients receive total arch replacement (TAR) combined with frozen elephant trunk (FET) implantation and are randomized to Group 1 (arch-clamping technique under mild hypothermia), Group 2 (arch-clamping technique under moderate hypothermia) and Group 3 (Sun's procedure using bilateral antegrade cerebral perfusion) in the ratio of 1:1:1. After a 1-year follow-up, the validity and safety of the mild hypothermic arch-clamping technique for ATAAD was evaluated via the incidence of major adverse events including death, renal replacement therapy, stroke, and paraplegia, as well as times of circulatory arrest, cardiopulmonary bypass, and mechanical ventilation, and length of ICU stay.

Enrollment

306 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Aortic CTA confirmed as ATAAD according to the 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease;
  2. Adult patients (18-70 years) weighing 50-120 kg;
  3. Time interval between the onset of symptoms and operation is less than 14 days;
  4. Indications for total aortic arch replacement are available;
  5. Signed informed consent and availability for follow-up.

Exclusion criteria

  1. History of chronic renal failure, hepatocirrhosis, and hepatic insufficiency;
  2. Severe gastrointestinal complications of non-aortic dissection, such as mesenteric ischemia, gastrointestinal bleeding, hepatopancreaticobiliary dysfunction, and intestinal obstruction;
  3. History of severe cerebral infarction (with cerebral infarction sequels);
  4. Preoperative intubation or unconsciousness;
  5. Inflammatory aortic diseases, such as Takayasu arteritis and Behçet's disease, etc;
  6. History of infectious aortic diseases;
  7. History of cardiac and aortic surgery;
  8. History of malignancy or previous radiotherapy;
  9. Pregnant or feeding women, or anyone planning to reproduce during the test period;
  10. Without an informed consent signature;
  11. Participating in any other clinical trial;
  12. Having other causes not eligible for operation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

306 participants in 3 patient groups

Arch-clamping under mild hypothermia
Experimental group
Description:
TAR + FET procedure is performed using arch-clamping technique under mild hypothermia.
Treatment:
Procedure: Arch-Clamping Technique under Mild Hypothermia
Arch-clamping under moderate hypothermia
Experimental group
Description:
TAR + FET procedure is performed using arch-clamping technique under moderate hypothermia.
Treatment:
Procedure: Arch-Clamping Technique under Moderate Hypothermia
Sun's procedure using bACP
Active Comparator group
Description:
Total arch replacement and frozen elephant trunk implantation with moderate hypothermic circulatory arrest.
Treatment:
Procedure: Total Arch Replacement combined Frozen Elephant Trunk Implantation using Bilateral Antegrade Cerebral Perfusion under Moderate Hypothermic Circulatory Arrest

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Su-Wei Chen, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems